Cuprina Holdings (cayman) LTD income statement

In fiscal 2025, Cuprina Holdings (cayman) LTD reported revenue of $38,204, up 5.6% on the year before, operating income of −$3.7m (a -9680.2% margin) and net income of −$3.6m, or −$17.48 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Cuprina Holdings (cayman) LTD: income statement, annual
Fiscal year	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Revenue	41	75	36	38
Cost of revenue	27	48	38	39
Gross profit	14	27	−2	−0
Research and development	213	125	181	174
Selling, general and administrative	655	698	1,049	3,524
Operating income	−853	−796	−1,231	−3,698
Interest expense	1	1	1	11
Net interest income	−1	−42	−28	−11
Provision for credit losses	−2	0	−2	−3
Income before tax	−789	−809	−1,129	−3,530
Net income	−794	−834	−1,168	−3,578
Diluted EPS	−$4.41	−$4.63	−$6.50	−$17.48
Diluted shares (average)	18m	18m	18m	20m
EBITDA	−832	−770	−1,200	−3,670

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: CUPR vs POAS CUPR vs PAVM CUPR vs NXL CUPR vs HSCS

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Cuprina Holdings (cayman) LTD's SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Cuprina Holdings (cayman) LTD.